Pdt Partners, LLC Mirum Pharmaceuticals, Inc. Transaction History
Pdt Partners, LLC
- $1.02 Billion
- Q3 2024
A detailed history of Pdt Partners, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 113,712 shares of MIRM stock, worth $5.26 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
113,712
Previous 39,363
188.88%
Holding current value
$5.26 Million
Previous $1.35 Million
229.67%
% of portfolio
0.43%
Previous 0.14%
Shares
7 transactions
Others Institutions Holding MIRM
# of Institutions
190Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$304 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$207 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$159 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$150 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$142 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.7B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...